通过优化药物 (PRISM) 在熟练护理设施中预防伤害,这是一个集群随机试验的协议,旨在减少急性护理后伤害性跌倒
Sarah D Berry1,2, Mark Toles3, Thomas G Travison4,5
1Hinda and Arthur Marcus Institute for Aging Researchand, Hebrew SeniorLife, Boston, MA, USA. SarahBerry@hsl.harvard.edu.
Trials
|September 27, 2025
概括
这项研究调查了药物优化模型,以减少骨折后在熟练护理设施 (SNFs) 中的摔倒伤害. 结果将指导有效的策略,以提高患者安全和改善后急性护理环境的结果.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 在熟练护理设施 (SNFs) 中,骨折后的患者面临着高风险的跌倒相关伤害.
- 药物管理优化是缓解这些风险的潜在策略.
- 通过优化药物 (PRISM) 在熟练护理设施中预防受伤的试验协议是详细的.
研究的目的:
- 为了比较三个不同的护理模式在减少后急性SNF骨折患者中伤害性跌倒的有效性.
- 评估以患者为中心的结果,包括药物负担,焦虑,抑郁,疼痛和睡眠.
- 评估与每个护理模式相关的安全结果.
主要方法:
- 一个集群交叉随机对照试验,涉及42个SNF和匹配的对照.
- 顺序实施三种基于证据的护理模式:降低处方,骨健康和联合伤害预防模型.
- 使用Medicare索赔数据,招募最近骨折的患者 (目标n=3780),平均随访2年.
主要成果:
- 主要结局:事故造成伤害的跌倒.
- 二次结果:过程测量 (坚持) 和患者在90天后报告的结果.
- 将在三个模型中比较安全结果.
结论:
- 集群交叉试验将比较三个护理模型中的患者结果,并与匹配的对照进行比较.
- 结果将为利益相关者提供最有效的模型,以改善老年人SNF骨折后的结果.
相关概念视频
Drug Dosing: Geriatric Patients
199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
200
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
200
Pharmacodynamics in Geriatric Patients: Effects of Age
172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172
Drug Therapy
226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
226


